Results 131 to 140 of about 374,365 (198)

Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications. [PDF]

Contraception
Dutton C, Mody SK, Nippita S, Dodge LE, Pang T, Pennell PB, Davis A.   +6 more
europepmc   +1 more source

Contraceptive method continuation among a prospective cohort study of Malawian women on antiretroviral treatment initiating the Levonorgestrel Implant or the Depot Medroxyprogesterone Acetate Injectable for pregnancy prevention (the FP-ART study). [PDF]

AIDS Care
Hagey J, Liu X, Mollan K, Diepstra K, Lemani C, Chapola J, Bula A, Winston J, Chinula L, Hosseinipour M, Phiri S, Appiagyei A, Hudgens M, Tang JH.   +13 more
europepmc   +1 more source

Acceptance, Adherence, and Side Effects of Depot Medroxyprogesterone Acetate: A Prospective Observational Study. [PDF]

Cureus
Rajaraman R, Vaithilingan S, Selvavinayagam TS.   +2 more
europepmc   +1 more source

Spatial transcriptomics unveils estrogen-modulated immune responses and structural alterations in the ectocervical mucosa of depot medroxyprogesterone acetate users. [PDF]

Sci Rep
Kaldhusdal V, Boger MF, Tjernlund A, Burgener AD, Bradley F, Lajoie J, Omollo K, Kimani J, Fowke K, Czarnewski P, Broliden K.   +10 more
europepmc   +1 more source

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA). [PDF]

Contraception, 2020
Katz M, Newmark RL, Aronstam A, O'Grady N, Strome S, Rafie S, Karlin J.   +6 more
europepmc   +1 more source

Injection Depot Medroxyprogesterone Acetate as an Early Postpartum Contraceptive Measure: Evaluation of Its Acceptability, Efficacy, and Impact on Lactation. [PDF]

Cureus
Srivastava Garg S, Bhateja B, Grover S, Tapasvi I.   +3 more
europepmc   +1 more source

Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception. [PDF]

AIDS
Heffron R, Muwonge TR, Thomas KK, Zewdie K, Ssebuliba T, Stein G, Morrison S, Badaru J, Nakyanzi A, Bambia F, Mugwanya K, Wyatt C, Matovu F, Yin MT, Mujugira A.   +14 more
europepmc   +1 more source

Correction to: Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. [PDF]

Clin Infect Dis, 2023
europepmc   +1 more source

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. [PDF]

PLoS One
Avenant C, Singata-Madliki M, Bick AJ, Africander D, Balakrishna Y, Storbeck KH, Moliki JM, Dlamini S, Skosana S, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Hofmeyr GJ, Hapgood JP.   +15 more
europepmc   +1 more source

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. [PDF]

PLoS One
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.   +17 more
europepmc   +1 more source